This bill prevents federal officials from finalizing, implementing, administering, or enforcing the July 18, 2016 proposed rule titled "Importation of Sheep, Goats, and Certain Other Ruminants" and directs USDA to study the rule’s economic and animal‑health impacts. The prohibitions last from enactment until one year after USDA delivers a statutorily required report to specified Congressional committees.
USDA must produce a detailed study and, within one year of enactment, submit a report that analyzes projected import volumes and market effects, assesses herd health and disease risks, accounts for COVID-19’s impact on relevant data, and offers recommendations to eliminate or mitigate negative effects. The report must go to multiple Senate and House committees, creating a Congressional record to guide any future action on the rule.
At a Glance
What It Does
The bill bars federal officials from taking any final or enforcement steps on the 2016 proposed APHIS rule on importing sheep, goats, and related products until USDA completes and transmits a statutorily defined study and report. The prohibition covers finalizing, implementing, administering, or enforcing the specified proposed rule.
Who It Affects
U.S. sheep and goat producers, live‑animal and meat importers and processors, state agriculture agencies, and USDA/APHIS staff who would manage import rules and inspections. It also affects foreign producers whose access could be altered if the rule were implemented.
Why It Matters
The measure pauses regulatory change that could reshape domestic supply, prices, and trade flows for sheep and goat products while forcing an economic and animal‑health study to inform policymakers. That makes this bill consequential for market planning, trade partners, and federal biosecurity policy.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill creates a temporary moratorium on any federal action to finalize or enforce a particular APHIS import rule from 2016 concerning sheep, goats, and certain other ruminants and products derived from them. From the moment the bill is enacted, USDA and other federal actors must refrain from moving forward on that specific rule until the agency completes a congressionally defined study and then waits one additional year after filing the required report.
The bill explicitly references the Federal Register notice (July 18, 2016; 81 Fed. Reg. 46619) to identify the proposal it pauses.
USDA must carry out a multi‑part study that quantifies both economic and animal‑health effects tied to the rule. The agency must estimate how much additional meat and live animals would enter the U.S. market if the rule were implemented, project domestic demand for sheep and goat meat over the next ten years broken down by state and region, and analyze how the COVID‑19 pandemic distorts historical data and current market conditions.
The study also must evaluate effects on supply, prices, producer competitiveness, export opportunities, consumer confidence, herd health, and cross‑species disease outbreak risks, and it must try to account for any direct payments foreign governments might make to their producers that would affect competitiveness.After completing the study, USDA has one year from enactment to deliver a report to a set of House and Senate committees. That report must summarize the study findings and recommend concrete changes to the proposed rule to eliminate or mitigate harms the agency identifies.
By sending the analysis to Agriculture, Foreign Affairs/Relations, Finance, Oversight, and Homeland Security committees, the bill builds a multi‑committee review trigger for any future regulatory action and creates an explicit Congressional information requirement before the rule can proceed.
The Five Things You Need to Know
The bill prohibits USDA and other federal officials from finalizing, implementing, administering, or enforcing the July 18, 2016 proposed rule (81 Fed. Reg. 46619) on imports of sheep, goats, and related products during the covered period.
The covered period runs from enactment until one year after USDA submits the statutorily required report to Congress.
USDA must estimate import volumes of sheep and goat meat and live animals attributable to the rule and project domestic demand for sheep and goat meat over a 10‑year horizon, disaggregated by State and region.
The study must evaluate market effects (supply, prices, competitiveness, export opportunities), consumer confidence, herd health and cross‑species disease risks, and whether foreign governments provide direct payments to their producers because of the rule.
USDA must submit the report within one year of enactment to specified Senate committees (Agriculture; Foreign Relations; Finance; Homeland Security and Governmental Affairs) and House committees (Agriculture; Foreign Affairs; Oversight and Reform), and include recommendations to mitigate any negative effects.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Moratorium on action regarding the 2016 proposed APHIS rule
This subsection creates the operative prohibition: from enactment until the statutory end date, the Secretary of Agriculture and other federal officials may not finalize, implement, administer, or enforce the named proposed rule. The provision is categorical in the verbs it uses, covering the full arc of rulemaking and enforcement activity, which prevents interim measures tied to that proposal during the pause.
Required USDA study: scope and analytic elements
USDA must conduct a comprehensive study of the economic and animal‑health consequences of implementing the proposed import rule. The statute prescribes a long checklist: projected import volumes of meat and live animals, a 10‑year demand forecast disaggregated by State/region, COVID‑19’s effects on baseline data, market impacts (supply, prices, producer markets), trade and export implications, consumer confidence, herd health and disease outbreak considerations, and identification of any direct foreign payments to producers. That prescriptive scope limits agency discretion over what to analyze but leaves methodological choices (data sources, modeling approach) to USDA.
Reporting duties and Congressional recipients
Within one year of enactment, USDA must deliver a report to a specified set of Senate and House committees that summarizes the study findings and gives recommendations to eliminate or mitigate negative effects of the rule. The bill names committees across agriculture, foreign affairs, finance/oversight, and homeland security, signaling that the issue intersects trade, domestic markets, fiscal considerations, and biosecurity. The report requirement converts the study into a formal Congressional deliverable that lawmakers can use to condition or shape future regulatory steps.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- U.S. sheep and goat producers — The pause preserves the current regulatory status quo and delays potential increases in foreign competition that the bill hypothesizes could depress domestic prices and market share.
- State agricultural agencies and regional producers — The mandated, state‑level disaggregation of demand and market effects gives state authorities data to defend regional industry interests and inform local mitigation strategies.
- USDA/APHIS decision‑makers seeking more evidence — The statutory study provides a legislatively required evidence base before the agency changes import policy, reducing political pressure to act without additional analysis.
Who Bears the Cost
- Foreign exporters and international suppliers of sheep and goat meat — The moratorium stalls potential market access expansion that would follow implementation of the 2016 proposal, imposing opportunity costs on exporters.
- U.S. meat processors and import‑dependent distributors — Companies that rely on imported sheep and goat products face prolonged uncertainty and potential supply constraints or higher input costs while the rule is paused.
- USDA and taxpayers — USDA must carry out a wide‑ranging, state‑disaggregated study within a one‑year reporting window, which requires budget, staff, and technical resources with no appropriation specified in the bill.
Key Issues
The Core Tension
The central dilemma is whether to pause regulatory change to protect domestic producers and demand more evidence, at the cost of delaying potential biosecurity or trade‑opening measures; the bill privileges additional economic and health analysis but risks creating gaps in protections, imposing administrative burdens on USDA, and prolonging market uncertainty for importers and processors.
The bill ties regulatory pause to an agency study with a detailed analytic checklist, but it does not fund the work or specify methodology. USDA will therefore need to decide how to meet the statutory requirements—selecting data sources, modeling approach, and the degree of granularity for state and regional projections—while staying within existing resources and the one‑year report deadline.
That creates a risk the study will be compressed or rely on imperfect proxies, undermining the goal of producing robust, actionable findings.
Another implementation tension arises between trade and biosecurity objectives. The paused 2016 proposal was an APHIS‑led effort to revise import conditions; delaying that proposal can protect domestic producers in the short term but may also defer measures intended to address animal‑health risks or to align U.S. import policy with trading partners.
The bill requires analysis of disease risks and cross‑species outbreaks, but a study does not itself provide regulatory protections in the interim, potentially leaving a gap if the proposed rule contained biosecurity improvements.
Finally, several study elements are difficult to measure causally: estimating the portion of future imports 'as a result of' a regulation, quantifying foreign direct payments tied to a single rule, and separating COVID‑19‑related market distortions from structural trends. Those measurement challenges mean Congress and stakeholders may still disagree over the study’s conclusions, and the bill’s one‑year reporting timeline may aggravate—not resolve—debate about data quality and inference.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.